Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9530]

Comparing toxicity profiles for 72 hour infusional and conventional bleomycin...

Dr Jonathan Shamash - Barts Cancer Institute, London, UK

Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer ( Dr Jonathan Shamash - Barts Cancer Institute, London, UK )

Polygenic susceptibility: What might it tell us?

Sir Bruce Ponder - University of Cambridge, UK

Polygenic susceptibility: What might it tell us? ( Sir Bruce Ponder - University of Cambridge, UK )

Give early breast tumours fewer, larger doses of radiation, rather than more...

Prof John Yarnold - The Royal Marsden, London, UK

Give early breast tumours fewer, larger doses of radiation, rather than more, smaller doses ( Prof John Yarnold - The Royal Marsden, London, UK )

Diet, the microbiome, and colon cancer risk

Dr Stephen O' Keefe - University of Pittsburgh, USA

Diet, the microbiome, and colon cancer risk ( Dr Stephen O' Keefe - University of Pittsburgh, USA )

UK fight for tobacco control

Prof Linda Bauld - University of Stirling, Stirling, UK

UK fight for tobacco control ( Prof Linda Bauld - University of Stirling, Stirling, UK )

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA

Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )

ecancerNews November Round Up

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancerNews November Round Up ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Editor’s Choice - ecancermedicalscience November 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

Editor’s Choice - ecancermedicalscience November 2013 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

The future of CLL treatment: balancing efficacy, safety and cost

Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA

The future of CLL treatment: balancing efficacy, safety and cost ( Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA )

Making sense of the expanding armoury of treatment options for the less fit CLL...

Dr Valentin Goede - Uniklinik Köln, Cologne, Germany

Making sense of the expanding armoury of treatment options for the less fit CLL patient ( Dr Valentin Goede - Uniklinik Köln, Cologne, Germany )

‘Go-Go’ CLL patients: a look towards the future

Professor Clemens Wendtner - Klinikum Schwabing, Munich, Germany

‘Go-Go’ CLL patients: a look towards the future ( Professor Clemens Wendtner - Klinikum Schwabing, Munich, Germany )

The economic burden of CLL treatment now and in the future

Dr George Follows - Addenbrooke’s Hospital, Cambridge, UK

The economic burden of CLL treatment now and in the future ( Dr George Follows - Addenbrooke’s Hospital, Cambridge, UK )

More from ecancer